Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
ContributorsAujesky, Drahomir; Roy, Pierre-Marie; Verschuren, Franck; Righini, Marc Philip; Osterwalder, Josef Johann; Egloff, Michaël; Renaud, Bertrand; Verhamme, Peter; Stone, Roslyn A; Legall, Catherine; Sanchez, Olivier; Pugh, Nathan A; N'gako, Alfred; Cornuz, Jacques; Hugli, Olivier; Beer, Hans-Jürg; Perrier, Arnaud; Fine, Michael J; Yealy, Donald M
Published inLancet, vol. 378, no. 9785, p. 41-48
Publication date2011
Abstract
Keywords
- Acute Disease
- Administration, Oral
- Ambulatory Care
- Anticoagulants/administration & dosage/adverse effects
- Enoxaparin/administration & dosage/adverse effects
- Female
- Health Resources/utilization
- Hemorrhage/chemically induced
- Hospitalization
- Humans
- Injections, Subcutaneous
- Length of Stay
- Male
- Middle Aged
- Outcome Assessment (Health Care)
- Patient Readmission
- Patient Satisfaction
- Pulmonary Embolism/diagnosis/drug therapy
- Recurrence
Affiliation
Citation (ISO format)
AUJESKY, Drahomir et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. In: Lancet, 2011, vol. 378, n° 9785, p. 41–48. doi: 10.1016/S0140-6736(11)60824-6
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25576
- DOI : 10.1016/S0140-6736(11)60824-6
- PMID : 21703676
ISSN of the journal0140-6736
